A detailed history of Plato Investment Management LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 413 shares of MRNA stock, worth $24,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares
413
Previous 125 230.4%
Holding current value
$24,247
Previous $13.3 Million 268.2%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$101.21 - $166.61 $29,148 - $47,983
288 Added 230.4%
413 $49 Million
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $8,688 - $13,053
125 New
125 $12.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $23B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.